• Describe our current understanding of the spatiotemporal spread of tau in Alzheimer’s Disease, based on the latest imaging and biomarker research. ​
  • ​Identify promising areas of research for furthering our understanding of the factors influencing tau dissemination. ​
  • ​Summarize the potential applications of the above knowledge in diagnosis, prognosis and novel treatment approaches for Alzheimer’s Disease, including noninvasive brain stimulation. ​

Session date: 
02/24/2025 - 4:00pm to 5:00pm CST
Location: 
In-person and Virtually
1685 Highland Ave
MFCB-Room 1220
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report